SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine–Glycine–One-Carbon Pathways in Cancer

Vaupel, 2019, The Warburg effect: Essential part of metabolic reprogramming and central con-tributor to cancer progression, Int. J. Radiat. Biol., 95, 912, 10.1080/09553002.2019.1589653

Mazurek, 2020, Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer, Semin. Cell Dev. Biol., 98, 34, 10.1016/j.semcdb.2019.05.012

Corbet, 2015, Metabolic and mind shifts: From glucose to glutamine and acetate addictions in cancer, Curr. Opin. Clin. Nutr. Metab. Care, 18, 346, 10.1097/MCO.0000000000000178

Moscat, 2020, The complexity of the serine glycine one-carbon pathway in cancer, J. Cell Biol., 219, e201907022, 10.1083/jcb.201907022

Dando, 2019, Oncometabolites in cancer aggressiveness and tumour repopulation, Biol. Rev., 94, 1530, 10.1111/brv.12513

Ristic, 2017, Cell-surface G-protein-coupled receptors for tumor-associated metabolites: A direct link to mitochondrial dysfunction in cancer, Biochim. Biophys. Acta Bioenergy, 1868, 246

Mishra, D., and Banerjee, D. (2019). Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment. Cancers, 11.

Bartrons, 2018, Fructose 2,6-Bisphosphate in Cancer Cell Metabolism, Front. Oncol., 8, 331, 10.3389/fonc.2018.00331

Payen, 2020, Monocarboxylate transporters in cancer, Mol. Metab., 33, 48, 10.1016/j.molmet.2019.07.006

Hirayama, 2016, Revisiting the physiological roles of SGLTs and GLUTs using positron emission tomography in mice, J. Physiol., 594, 4425, 10.1113/JP271904

Brown, 2020, Lactate/GPR81 signaling and proton motive force in cancer: Role in angiogenesis, immune escape, nutrition, and Warburg phenomenon, Pharmacol. Ther., 206, 107451, 10.1016/j.pharmthera.2019.107451

Baltazar, 2020, Lactate Beyond a Waste Metabolite: Metabolic Affairs and Signaling in Malignancy, Front. Oncol., 10, 231, 10.3389/fonc.2020.00231

Reitzer, 1979, Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells, J. Biol. Chem., 254, 2669, 10.1016/S0021-9258(17)30124-2

Mancuso, 2007, Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis, Proc. Natl. Acad. Sci. USA, 104, 19345, 10.1073/pnas.0709747104

Dorai, T., Dorai, B., Pinto, J.T., Grasso, M., and Cooper, A.J.L. (2019). High levels of glutamainase II pathway enzymes in normal and cancerous prostate suggest a role in “glutamine addiction”. Biomolecules, 10.

Udupa, 2019, Upregulation of the glutaminase II pathway contributes to glutamate production upon glutaminase 1 inhibition in pancreatic cancer, Proteomics, 19, e1800451, 10.1002/pmic.201800451

Mates, 2020, Metabolic reprogram-ming of cancer by chemicals that target glutaminase isoenzymes, Curr. Med. Chem., 27, 5317, 10.2174/0929867326666190416165004

Yoo, 2020, A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells, Cell Metab., 31, 267, 10.1016/j.cmet.2019.11.020

Stine, 2020, Glutamine Skipping the Q into Mitochondria, Trends Mol. Med., 26, 6, 10.1016/j.molmed.2019.11.004

Parker, 2015, Metabolic consequences of oncogenic IDH mutations, Pharmacol. Ther., 152, 54, 10.1016/j.pharmthera.2015.05.003

Kunji, 2020, The SLC25 Carrier Family: Important Transport Proteins in Mitochondrial Physiology and Pathology, Physiology, 35, 302, 10.1152/physiol.00009.2020

Zhao, 2020, The Role of D-3-Phosphoglycerate Dehydrogenase in Cancer, Int. J. Biol. Sci., 16, 1495, 10.7150/ijbs.41051

Kes, M.M., Bossche, J.V.D., Griffioen, A.W., and Huijbers, E.J. (2020). Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors. Biochim. Biophys. Acta Bioenergy, 188427.

Yong, 2020, Oncometabolites in renal cancer, Nat. Rev. Nephrol., 16, 156, 10.1038/s41581-019-0210-z

Moog, 2020, Epigenetic and metabolic reprogramming of SDH-deficient paragangliomas, Endocr. Relat. Cancer, 27, R451, 10.1530/ERC-20-0346

Waitkus, 2021, Targeting Isocitrate Dehydrogenase Mutations in Cancer: Emerging Evidence and Diverging Strategies, Clin. Cancer Res., 27, 383, 10.1158/1078-0432.CCR-20-1827

Fletcher, 2020, Human 2-oxoglutarate-dependent oxygenases: Nutrient sensors, stress responders, and disease mediators, Biochem. Soc. Trans., 48, 1843, 10.1042/BST20190333

Linker, 2011, Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway, Brain, 134, 678, 10.1093/brain/awq386

Lewerenz, 2013, The Cystine/Glutamate Antiporter System xc− in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities, Antioxid. Redox Signal., 18, 522, 10.1089/ars.2011.4391

Ananth, 2013, Induction of the Cystine/Glutamate Exchanger SLC7A11 in Retinal Pigment Epithelial Cells by the Antipsoriatic Drug Monomethylfumarate, Investig. Opthalmol. Vis. Sci., 54, 1592, 10.1167/iovs.12-11289

Liu, 2020, xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling, Mol. Ther., 28, 2358, 10.1016/j.ymthe.2020.08.021

Wang, 2016, Mitochondrial dysfunction enhances cisplatin resistance in human gastric cancer cells via the ROS-activated GCN2-eIF2α-ATF4-xCT pathway, Oncotarget, 7, 74132, 10.18632/oncotarget.12356

Chen, 2017, The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas, Oncotarget, 8, 51164, 10.18632/oncotarget.17737

Wada, 2018, High expression of CD 44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine, Cancer Sci., 109, 2801, 10.1111/cas.13728

Magri, J., Gasparetto, A., Conti, L., Calautti, E., Cossu, C., Ruiu, R., Barutello, G., and Cavallo, F. (2021). Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies. Cells, 10.

Friso, 2017, One-carbon metabolism and epigenetics, Mol. Asp. Med., 54, 28, 10.1016/j.mam.2016.11.007

Yang, 2016, Serine and one-carbon metabolism in cancer, Nat. Rev. Cancer, 16, 650, 10.1038/nrc.2016.81

Meiser, 2016, Give it or take it: The flux of one-carbon in cancer cells, FEBS J., 283, 3695, 10.1111/febs.13731

Ducker, 2017, One-Carbon Metabolism in Health and Disease, Cell Metab., 25, 27, 10.1016/j.cmet.2016.08.009

Goel, 2020, PRMT5 and Tip60 Modify FOXP3 Function in Tumor Immunity, Crit. Rev. Immunol., 40, 283, 10.1615/CritRevImmunol.2020034789

Xie, 2020, Protein arginine methylation promotes therapeutic resistance in human pancreatic cancer, Cytokine Growth Factor Rev., 55, 58, 10.1016/j.cytogfr.2020.07.011

Guccione, 2019, The regulation, functions and clinical relevance of arginine methylation, Nat. Rev. Mol. Cell Biol., 20, 642, 10.1038/s41580-019-0155-x

Backlund, 1982, Identification of 2-keto-4-methylthiobutyrate as an intermediate compound in methionine synthesis from 5’-methylthioadenosine, J. Biol. Chem., 257, 4196, 10.1016/S0021-9258(18)34705-7

Wray, 1995, The Methionine Salvage Pathway in Klebsiella pneumoniae and Rat Liver, J. Biol. Chem., 270, 3147, 10.1074/jbc.270.7.3147

Cooper, 2004, The role of glutamine transaminase K (GTK) in sulfur and α-keto acid metabolism in the brain, and in the possible bioactivation of neurotoxicants, Neurochem. Int., 44, 557, 10.1016/j.neuint.2003.12.002

Ganapathy, 2009, Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond, Pharmacol. Ther., 121, 29, 10.1016/j.pharmthera.2008.09.005

Bhutia, 2016, Glutamine transporters in mammalian cells and their functions in physiology and cancer, Biochim. Biophys. Acta Bioenergy, 1863, 2531, 10.1016/j.bbamcr.2015.12.017

Bhutia, 2015, Amino Acid Transporters in Cancer and Their Relevance to “Glutamine Addiction”: Novel Targets for the Design of a New Class of Anticancer Drugs, Cancer Res., 75, 1782, 10.1158/0008-5472.CAN-14-3745

Cormerais, Y., Vučetić, M., Parks, S.K., and Pouyssegur, J. (2020). Amino Acid Transporters Are a Vital Focal Point in the Control of mTORC1 Signaling and Cancer. Int. J. Mol. Sci., 22.

Scalise, 2020, Glutamine transporters as pharmacological targets: From function to drug design, Asian J. Pharm. Sci., 15, 207, 10.1016/j.ajps.2020.02.005

Nakanishi, 2001, Structure, Function, and Tissue Expression Pattern of Human SN2, a Subtype of the Amino Acid Transport System N, Biochem. Biophys. Res. Commun., 281, 1343, 10.1006/bbrc.2001.4504

Nakanishi, 2001, Cloning and functional characterization of a new subtype of the amino acid transport system N, Am. J. Physiol. Physiol., 281, C1757, 10.1152/ajpcell.2001.281.6.C1757

Wise, 2008, Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction, Proc. Natl. Acad. Sci. USA, 105, 18782, 10.1073/pnas.0810199105

Ganapathy, 2005, Amino Acid Transporter ATB0,+ as a Delivery System for Drugs and Prodrugs, Curr. Drug Targets Immune Endocr. Metab. Disord., 5, 357, 10.2174/156800805774912953

Sikder, 2017, The Na+/Cl−-Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB0,+): Emerging Roles in Multiple Diseases and Therapeutic Potential for Treatment and Diagnosis, AAPS J., 20, 12, 10.1208/s12248-017-0164-7

2020, Amino Acid Transporter SLC6A14 (ATB0,+)—A Target in Combined Anti-cancer Therapy, Front. Cell Dev. Biol., 8, 594464, 10.3389/fcell.2020.594464

2013, The SLC38 family of sodium–amino acid co-transporters, Pflügers Arch. Eur. J. Physiol., 466, 155

Umapathy, 2005, Expression and function of glutamine transporters SN1 (SNAT3) and SN2 (SNAT5) in retinal Muller cells, Investig. Ophthalmol. Vis. Sci., 46, 3980, 10.1167/iovs.05-0488

Jenstad, 2013, The Amino Acid Transporters of the Glutamate/GABA-Glutamine Cycle and Their Impact on Insulin and Glucagon Secretion, Front. Endocrinol., 4, 199, 10.3389/fendo.2013.00199

Oberleithner, 1992, Oscillations: A key event in transformed renal epithelial cells, J. Mol. Med., 70, 816

Flinck, 2018, Roles of pH in control of cell proliferation, Acta Physiol., 223, e13068, 10.1111/apha.13068

Pedersen, 2006, The Na+/H+ exchanger NHE1 in stress-induced signal transduction: Implications for cell proliferation and cell death, Pflügers Arch. Eur. J. Physiol., 452, 249, 10.1007/s00424-006-0044-y

Devadas, 2014, Herpes Simplex Virus Internalization into Epithelial Cells Requires Na+/H+ Exchangers and p21-Activated Kinases but neither Clathrin- nor Caveolin-Mediated Endocytosis, J. Virol., 88, 13378, 10.1128/JVI.03631-13

Palm, 2019, Metabolic functions of macropinocytosis, Philos. Trans. R. Soc. B Biol. Sci., 374, 20180285, 10.1098/rstb.2018.0285

Stow, J.L., Hung, Y., and Wall, A.A. (2020). Macropinocytosis: Insights from immunology and cancer. Curr. Opin. Cell Biol., 65, 131–140.

Derle, 2018, The role of metabolic adaptation to nutrient stress in pancreatic cancer, Cell Stress, 2, 332, 10.15698/cst2018.12.166

Pupo, 2019, KRAS-Driven Metabolic Rewiring Reveals Novel Actionable Targets in Cancer, Front. Oncol., 9, 848, 10.3389/fonc.2019.00848

Gupta, 2005, Upregulation of the amino acid transporter ATB0,+ (SLC6A14) in colorectal cancer and metastasis in humans, Biochim. Biophys. Acta Mol. Basis Dis., 1741, 215, 10.1016/j.bbadis.2005.04.002

Sikder, 2020, SLC6A14, a Na+/Cl−-coupled amino acid transporter, functions as a tumor promoter in colon and is a target for Wnt signaling, Biochem. J., 477, 1409, 10.1042/BCJ20200099

Gupta, 2006, Up-reguation of the amino acid transporter ATB0,+ (SLC6A14) in carcinoma of the cervix, Gynecol. Oncol., 100, 8, 10.1016/j.ygyno.2005.08.016

Royse, 2014, Differential gene expression landscape of co-existing cervical pre-cancer lesions using RNA-seq, Front. Oncol., 4, 339, 10.3389/fonc.2014.00339

Karunakaran, 2008, Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy, Biochem. J., 414, 343, 10.1042/BJ20080622

Karunakaran, 2011, SLC6A14 (ATB0,+) Protein, a Highly Concentrative and Broad Specific Amino Acid Transporter, Is a Novel and Effective Drug Target for Treatment of Estrogen Receptor-positive Breast Cancer, J. Biol. Chem., 286, 31830, 10.1074/jbc.M111.229518

Babu, 2015, Deletion of the amino acid transporter Slc6a14 suppresses tumour growth in spontaneous mouse models of breast cancer, Biochem. J., 469, 17, 10.1042/BJ20150437

Penheiter, 2015, Transcriptomic and immunohistochemical profiling of SLC6A14 in pancreatic ductal adenocarcinoma, BioMed Res. Int., 2015, 593572, 10.1155/2015/593572

Coothankandaswamy, 2016, Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer, Br. J. Pharmacol., 173, 3292, 10.1111/bph.13616

Cheng, 2019, Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma, EBioMedicine, 40, 382, 10.1016/j.ebiom.2019.01.003

Li, 2020, Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma, Math. Biosci. Eng., 17, 910, 10.3934/mbe.2020048

Roche, S., O’Neill, F., Murphy, J., Swan, N., Meiller, J., Conlon, N.T., Geoghegan, J., Conlon, K., McDermott, R., and Rahman, R. (2020). Establishment and characterization by expression microarray of patient-derived xenograft panel of human pancreatic adenocarcinoma patients. Int. J. Mol. Sci., 21.

Chang, 2020, Bioinformatic Analysis Suggests That Three Hub Genes May Be a Vital Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma, J. Comput. Biol., 27, 1595, 10.1089/cmb.2019.0367

Sharma, M., and Pruitt, K. (2020). Wnt Pathway: An Integral Hub for Developmental and Oncogenic Signaling Networks. Int. J. Mol. Sci., 21.

Zhong, 2020, Wnts and the hallmarks of cancer, Cancer Metastasis Rev., 39, 625, 10.1007/s10555-020-09887-6

Girardi, 2020, A widespread role for SLC transmembrane transporters in resistance to cytotoxic drugs, Nat. Chem. Biol., 16, 469, 10.1038/s41589-020-0483-3

Talukder, 2008, Functional characterization, localization, and molecular identification of rabbit intestinal N-amino acid transporter, Am. J. Physiol. Liver Physiol., 294, G1301

Saha, 2012, Na-glutamine co-transporters B0AT1 in villus and SN2 in crypts are differentially altered in chronically inflamed rabbit intestine, Biochim. Biophys. Acta Biomembr., 1818, 434, 10.1016/j.bbamem.2011.11.005

Singh, 2015, Mast cell regulation of Na-glutamine co-transporters B0AT1 in villus and SN2 in crypt cells during chronic intestinal inflammation, BMC Gastroenterol., 15, 1, 10.1186/s12876-015-0275-5

Singh, 2017, Unique regulation of Na-glutamine cotransporter SN2/SNAT5 in rabbit intestinal crypt cells during chronic enteritis, J. Cell. Mol. Med., 22, 1443, 10.1111/jcmm.13257

Stanescu, 2017, Single cell transcriptomic profiling of mouse pancreatic progenitors, Physiol. Genom., 49, 105, 10.1152/physiolgenomics.00114.2016

Kim, 2017, Amino Acid Transporter Slc38a5 Controls Glucagon Receptor Inhibition-Induced Pancreatic α Cell Hyperplasia in Mice, Cell Metab., 25, 1348, 10.1016/j.cmet.2017.05.006

Dean, 2017, Interrupted Glucagon Signaling Reveals Hepatic α Cell Axis and Role for L-Glutamine in α Cell Proliferation, Cell Metab., 25, 1362, 10.1016/j.cmet.2017.05.011

Smith, 2020, Elevated Serum Amino Acids Induce a Subpopulation of Alpha Cells to Initiate Pancreatic Neuroendocrine Tumor Formation, Cell Rep. Med., 1, 100058, 10.1016/j.xcrm.2020.100058

Schafer, 2009, Differential gene expression in Ndph-knockout mice in retinal develop-ment, Investig. Ophthalmol. Vis. Sci., 50, 906, 10.1167/iovs.08-1731

Xia, C.-H., Yablonka-Reuveni, Z., and Gong, X. (2010). LRP5 Is Required for Vascular Development in Deeper Layers of the Retina. PLoS ONE, 5.

Chen, J., Stahl, A., Krah, N.M., Seaward, M.R., Joyal, J.-S., Juan, A.M., Hatton, C.J., Aderman, C.M., Dennison, R.J., and Willett, K.L. (2012). Retinal Expression of Wnt-Pathway Mediated Genes in Low-Density Lipoprotein Receptor-Related Protein 5 (Lrp5) Knockout Mice. PLoS ONE, 7.

Cai, 2020, Synergism between SLC6A14 blockade and gemcitabine in pancreactic cancer: A 1H-NMR-based metabolomic study in pancreatic cancer cells, Biochem. J., 477, 1923, 10.1042/BCJ20200275

Low, 1991, Substrate-specificity of glutamine transporters in membrane vesicles from rat liver and skeletal muscle investigated using amino acid analogues, Biochem. J., 278, 105, 10.1042/bj2780105